Company Operations in Response to Partial Lifting of COVID-19 Imposed State of Emergency
Our sincere condolences to victims of COVID-19, and we hope for the quick recovery of those who have been infected. We also offer sincere gratitude towards healthcare professionals who are working at the forefront to treat patients, and everyone who is helping to support the community infrastructure.
Responding to the Japanese Government’s recent decision to lift the state of emergency in certain regions, which was announced on May 21, PHC Holdings Corporation (headquarters: Tokyo, Japan) will be reopening the company sites below from May 25. However, as we prioritize the safety of customers and employees, those who work at our sites in the prefectures subject to the state of emergency, as well as employees who work at the reopening site below, will continue to work from home, except in special cases where they perform essential duties that cannot be performed remotely. At other sites in Japan where our offices are open, employees will continue to work from home as much as possible. When a customer visit is required, upon receipt of the customer’s consent, the visiting employee will strictly implement infection prevention measures such as temperature measurement, wearing of face masks, hand-washing, etc.
· Site reopening
||Osaka Site (Address: OAP Tower 16F, 1-8-30 Tenmabashi, Kita-ku, Osaka City)
| [Biomedical Division]
Kinki Sales Office/Pharmacy System Sales Office/Delicart Sales Office
| [Medical Information Systems Division]
West Japan Sales Office
Resuming of operations at other sites will be carefully considered, depending on government and local policies and the status of the COVID-19. We appreciate your understanding and apologize for any inconvenience or disruption that you may be experiencing as a result of these closures. Details about our operations for other PHC Group companies will be announced separately by each company and we ask you to refer to each company‘s website for further information.
The PHC Group will continue to protect the safety of our customers and employees, while minimizing the effects on customers and patients who rely on our products and services.